As of Friday, January 30, Apogee Therapeutics, Inc.’s APGE share price has dipped by 7.75%, which has investors questioning ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027Data from the ongoing parallel BROADEN2 Phase 2b atopic ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2025 Earnings Call Transcript January 28, 2026 Teva Pharmaceutical ...
Mounting evidence points to a link between new-onset allergies and Long COVID, with mast cell activation syndrome as a potential culprit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results